Pages that link to "Q34020606"
Jump to navigation
Jump to search
The following pages link to Conformational characterization of aberrant disulfide-linked HIV-1 gp120 dimers secreted from overexpressing cells. (Q34020606):
Displaying 29 items.
- A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies (Q28299280) (← links)
- Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern Africa (Q28552786) (← links)
- Solution structure, conformational dynamics, and CD4-induced activation in full-length, glycosylated, monomeric HIV gp120 (Q30524225) (← links)
- Glycosylation and disulfide bond analysis of transiently and stably expressed clade C HIV-1 gp140 trimers in 293T cells identifies disulfide heterogeneity present in both proteins and differences in O-linked glycosylation (Q34141693) (← links)
- Escherichia coli-expressed near full length HIV-1 envelope glycoprotein is a highly sensitive and specific diagnostic antigen (Q34491689) (← links)
- Analysis of the disulfide bond arrangement of the HIV-1 envelope protein CON-S gp140 ΔCFI shows variability in the V1 and V2 regions (Q34784833) (← links)
- Stabilization of HIV-1 Envelope in the CD4-bound Conformation through Specific Cross-linking of a CD4 Mimetic (Q35065249) (← links)
- Engineering and exploitation of a fluorescent HIV-1 gp120 for live cell CD4 binding assays (Q35070898) (← links)
- Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells (Q35833324) (← links)
- Lineage-specific differences between human and simian immunodeficiency virus regulation of gp120 trimer association and CD4 binding (Q36155019) (← links)
- Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion (Q36559838) (← links)
- The highly conserved layer-3 component of the HIV-1 gp120 inner domain is critical for CD4-required conformational transitions. (Q36607016) (← links)
- Native Conformation and Canonical Disulfide Bond Formation Are Interlinked Properties of HIV-1 Env Glycoproteins (Q36736597) (← links)
- Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies (Q36811996) (← links)
- Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopes (Q36827300) (← links)
- Purification of recombinant vaccinia virus-expressed monomeric HIV-1 gp120 to apparent homogeneity (Q37032195) (← links)
- Comprehensive Characterization of Reference Standard Lots of HIV-1 Subtype C Gp120 Proteins for Clinical Trials in Southern African Regions (Q37061940) (← links)
- Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein (Q37123584) (← links)
- A functional interaction between gp41 and gp120 is observed for monomeric but not oligomeric, uncleaved HIV-1 Env gp140. (Q37252789) (← links)
- Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors. (Q37318213) (← links)
- Native-like Env trimers as a platform for HIV-1 vaccine design (Q37633417) (← links)
- Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits (Q38989507) (← links)
- A Highly Conserved gp120 Inner Domain Residue Modulates Env Conformation and Trimer Stability (Q40664564) (← links)
- Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers (Q41447893) (← links)
- Topological analysis of HIV-1 glycoproteins expressed in situ on virus surfaces reveals tighter packing but greater conformational flexibility than for soluble gp120. (Q42572387) (← links)
- cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidate (Q46067893) (← links)
- Antibody-dependent cellular cytotoxicity in HIV infection (Q59352288) (← links)
- A Systematic Approach to HIV-1 Vaccine Immunogen Selection (Q89708295) (← links)
- Calcium Phosphate Nanoparticle-Based Vaccines as a Platform for Improvement of HIV-1 Env Antibody Responses by Intrastructural Help (Q90384404) (← links)